Delpor Inc - Company & Market Research Reports

Delpor company enables the sustained or pattern specific release of proteins, peptides, and small molecules through a small non-mechanical subcutaneous implant device. They use 3 different technologies: Prozor, Nanopor, and Delos Pump. Delpor was founded in 2009, its headquarters is situated in San Francisco, California. Delpors DLP-114 is a 3-6 month formulation of Risperidone. This product is using Delpors Prozor technology It is expected to maintain therapeutic levels of Risperidone and its active metabolite in human plasma.


Implantable Infusion Pumps Market Analysis & Trends- Application (Cancer Treatment, Cancer Pain, Noncancer Pain, Spasticity, Analgesia, Mixed Sarcoma and Skin Cancers, Gastric Cancer and Diabetes Mellitus) - Forecast to 2025 - Product Thumbnail Image

Implantable Infusion Pumps Market Analysis & Trends- Application (Cancer Treatment, Cancer Pain, Noncancer Pain, Spasticity, Analgesia, Mixed Sarcoma and Skin Cancers, Gastric Cancer and Diabetes Mellitus) - Forecast to 2025

  • Report
  • 159 Pages
From
Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - World Forecasts to 2022 - Product Thumbnail Image

Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - World Forecasts to 2022

  • Report
  • 75 Pages
From
Hepatitis Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Hepatitis Drug Development Pipeline Review, 2017

  • Report
  • 209 Pages
From
Schizophrenia - Pipeline Review, H1 2018 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H1 2018

  • Report
  • 334 Pages
From
D Antagonist -Pipeline Insight, 2018 - Product Thumbnail Image

D Antagonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 90 Pages
From
Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins) - Product Thumbnail Image

Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins)

  • Report
  • 301 Pages
From
Depression - Pipeline Review, H1 2018 - Product Thumbnail Image

Depression - Pipeline Review, H1 2018

  • Report
  • 490 Pages
From
Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2016 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2016

  • Report
  • 122 Pages
From
Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2016 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2016

  • Report
  • 126 Pages
From
Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2015 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2015

  • Report
  • 114 Pages
From
Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015

  • Report
  • 128 Pages
From
Global Nano Chemotherapy Market & Clinical Trials Outlook 2022 - Product Thumbnail Image

Global Nano Chemotherapy Market & Clinical Trials Outlook 2022

  • Report
  • 110 Pages
From
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017

  • Report
  • 254 Pages
From
Type 2 Diabetes - Pipeline Review, H1 2018 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H1 2018

  • Report
  • 1109 Pages
From
Type 2 Diabetes - Pipeline Review, H2 2017 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H2 2017

  • Report
  • 1126 Pages
From
Growth Hormone Deficiency - Pipeline Review, H2 2015 - Product Thumbnail Image

Growth Hormone Deficiency - Pipeline Review, H2 2015

  • Report
  • 111 Pages
From
Global Central Nervous System Disorders Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Central Nervous System Disorders Therapeutics Market 2016-2020

  • Report
  • 147 Pages
From
D1 Antagonist -Pipeline Insight, 2018 - Product Thumbnail Image

D1 Antagonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Delpor Inc. Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Delpor Inc. Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
  • 19 Results (Page 1 of 1)
Loading Indicator
adroll